![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF |
| Liver Diseases |
|
Free Subscription
1 Am J Pathol |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Liver Diseases is free of charge.
Complement Anaphylatoxin Receptors C3aR1 and C5aR1 Are Dual Contributors of
Chronic-Plus-Binge Induced Hepatic Inflammation and Injury.
Am J Pathol. 2026 May 29:S0002-9440(26)00156.
PubMed
Abstract available
Hepatic Senp2 deletion resolves the angiogenic switch in fibrosis via
beta-catenin/LECT2.
Biochem Biophys Res Commun. 2026;827:154021.
PubMed
Abstract available
Metabolic reprogramming in hepatic ischemia-reperfusion injury: crosstalk between
mitochondria, lipid metabolism, and ferroptosis.
Biochem Biophys Res Commun. 2026;827:154044.
PubMed
Abstract available
Dantrolene attenuates steatohepatitis and liver fibrosis by suppressing Ca(2+)
dysregulation.
Biochem Biophys Res Commun. 2026;827:154042.
PubMed
Abstract available
The expression status and clinical value of TIM-3 in intrahepatic
cholangiocarcinoma.
BMC Cancer. 2026 Jun 5. doi: 10.1186/s12885-026-16292.
PubMed
Abstract available
Antiviral therapy and hidden predictors of postoperative outcomes in
hepatocellular carcinoma.
BMC Cancer. 2026 Jun 5. doi: 10.1186/s12885-026-15825.
PubMed
Abstract available
Blood circulating C228T TERT gene promoter mutation is an independent factor for
the prognosis of HBV-related hepatocellular carcinoma.
BMC Cancer. 2026 Jun 3. doi: 10.1186/s12885-026-16271.
PubMed
Abstract available
A linear clinical prediction model and nomogram evaluating risk of portal vein
thrombosis in liver cirrhosis.
BMC Gastroenterol. 2026 Jun 4. doi: 10.1186/s12876-026-04939.
PubMed
Abstract available
Transjugular intrahepatic portosystemic shunt for hepatic sinusoidal obstruction
syndrome induced by pyrrolizidine alkaloid.
BMC Gastroenterol. 2026 Jun 2. doi: 10.1186/s12876-026-04965.
PubMed
Abstract available
Combining preoperative clinical and ultrasound radiomic features to predict the
predominant component of combined hepatocellular carcinoma-cholangiocarcinoma.
BMC Gastroenterol. 2026 Jun 1. doi: 10.1186/s12876-026-04966.
PubMed
Abstract available
Validity of a seven-gene signature as a non-invasive biomarker for cirrhosis: a
cross-sectional study in Egyptian patients with HBV infection.
BMC Gastroenterol. 2026;26:332.
PubMed
Abstract available
The landscape of pediatric hepatocellular carcinoma and fibrolamellar carcinoma:
A report from the Children's Hepatic tumors International Collaboration (CHIC).
Cancer. 2026;132:e70413.
PubMed
Abstract available
Clinical Outcomes of Reintervention After Endoscopic Ultrasound-Guided
Hepaticogastrostomy Using a Partially Covered Self-Expandable Metal Stent.
Dig Dis Sci. 2026 Jun 1. doi: 10.1007/s10620-026-10035.
PubMed
Abstract available
Exploratory Comparison of Meld, Meld-Na, and Meld 3.0 Scores for Prognostic
Assessment at Diagnosis in Hepatocellular Carcinoma Using Machine Learning
Approaches.
Dig Dis Sci. 2026 May 30. doi: 10.1007/s10620-026-10032.
PubMed
Abstract available
Hepatic steatosis in pediatric obesity: association with cardiometabolic profile
and considerations regarding alanine aminotransferase screening.
Eur J Pediatr. 2026;185:468.
PubMed
Abstract available
Clinical utility of a novel index for predicting metabolic dysfunction-associated
steatotic liver disease risk in children.
Eur J Pediatr. 2026;185:454.
PubMed
Abstract available
Corrigendum to "Improved clinical outcomes of patients with cirrhosis and acute
variceal bleeding over the last 2 decades." Gastrointest Endosc 2025;102:733-7.
Gastrointest Endosc. 2026 Jun 2:S0016-5107(26)00280.
PubMed
Context matters for SMYD2 in liver disease: from hepatoprotection to tumour
immune escape.
Gut. 2026 Jun 3:gutjnl-2026-339533. doi: 10.1136/gutjnl-2026-339533.
PubMed
Outcomes of Y90-radioembolization as downstaging to liver transplantation in
patients with hepatocellular carcinoma and tumoral portal vein thrombosis.
Hepatology. 2026 Jun 2. doi: 10.1097/HEP.0000000000001801.
PubMed
Abstract available
Non-transcriptional activity of IRF3 promotes liver fibrosis and stress granule
assembly via a dsRNA-TLR3-dependent pathway in hepatic stellate cells.
Hepatology. 2026 Jun 2. doi: 10.1097/HEP.0000000000001803.
PubMed
Abstract available
Spit happens: Microbial and metabolic clues to cirrhosis hospitalization.
Hepatology. 2026;83:1345-1346.
PubMed
Comment on "Evaluation of Factors Affecting Alpha Fetoprotein Levels in Patients
With Hepatocellular Carcinoma in a Large Multicenter Cohort".
J Gastroenterol Hepatol. 2026 May 29. doi: 10.1111/jgh.70470.
PubMed
The versatile interplay between steatotic liver disease and liver cancer.
Nat Rev Cancer. 2026;26:415-436.
PubMed
Abstract available
Intratumoral bicarbonate functions as an adjuvant to potentiate PD-1 blockade in
hepatocellular carcinoma.
Oncogene. 2026 Jun 5. doi: 10.1038/s41388-026-03836.
PubMed
Abstract available
Exploring the roles of genes associated with leukocyte transendothelial migration
in liver cirrhosis development.
PLoS One. 2026;21:e0350886.
PubMed
Abstract available
Types of genotypes in progressive familial intrahepatic cholestasis and liver
transplantation: A meta-analysis of observational studies.
PLoS One. 2026;21:e0350508.
PubMed
Abstract available
Evaluating Accuracy of LI-RADS Nonradiation Treatment Response Algorithm v2024
and Ancillary Features at Hepatobiliary MRI versus CT.
Radiology. 2026;319:e253143.
PubMed
Abstract available
Thank you for your interest in scientific medicine.